<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[56, 60] patients with advanced NPC.<br>[65, 88] December 1993 to April 1999, 284 patients with 1992 American Joint Committee on Cancer stage III to IV (M0) NPC<br></td>
<td width=33%>
[10, 14] advanced nasopharyngeal carcinoma:<br>[56, 60] patients with advanced NPC.<br>[64, 87] From December 1993 to April 1999, 284 patients with 1992 American Joint Committee on Cancer stage III to IV (M0)<br>[87, 88] NPC<br>[334, 338] patients with advanced NPC<br></td>
<td width=33%>
[10, 14] advanced nasopharyngeal carcinoma:<br>[27, 33] carcinoma (NPC) is a<br>[56, 60] patients with advanced NPC.<br>[64, 87] From December 1993 to April 1999, 284 patients with 1992 American Joint Committee on Cancer stage III to IV (M0)<br>[87, 91] NPC were randomly allocated<br>[334, 338] patients with advanced NPC<br></td>
</tr>
